Print This PageBookmark this PageEmail this Page

ATOPIC DERMATITIS

Oral Therapy: Tridipitant NK-1 antagonist (VLY-686)

DO YOU MEET THESE REQUIREMENTS?

  • Male of female
  • Aged 18-70
  • Diagnosed with Atopic Dermatitis
    • >5% Body Surface Area of Atopic Dermatitis involvement
    • Suffering from chronic pruritus despite the use of antihistamines or corticosteroids

6 visits during a 8 week period; Travel reimbursements-$55 per visits.

The Dermatology Group Location: Verona, NJ

For more information, call 1-(973)571-2121 ext. 5920 or email ctrials@thedermgroup.com

 

Or Contact The Verona Research Hotline 1-201-478-9119 Call or Text

The medication, procedures, and all study visits are provided without financial costs to you.  No insuranace coverage is required.  All enrolled participants will be compensated for their time and travel at the completion of the study.

 

SC Injection Therapy: Anti-Interleukin-33 therapeutic anitibody (ANB020-005)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female
  • Aged 18-75 years
  • With moderate to severe AD
  • Clinically confirmed diagnosis of AD with symptoms present for at least 6-months
  • BSA ≥ 10%
  • History of inadequate response to topical treatments or for whom topical treatment is medically inadvisable

11 visits during a 24 week period; Travel reimbursement-$55 per visit.

The Dermatology Group Location: Verona, NJ

For more information, call 1-(973)571-2121 ext. 5920 or email ctrials@thedermgroup.com

 

Or Contact The Verona Research Hotline 1-201-478-9119 Call or Text

The medication, procedures, and all study visits are provided without financial costs to you.  No insuranace coverage is required.  All enrolled participants will be compensated for their time and travel at the completion of the study.

SC Injection Therapy: G1 antibody specific for OX40 CD134 (GBR830)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female
  • Aged 18 years and above
  • With moderate to severe AD which cannot be controlled with topical medication or for whom topical medication is medically inadvisable
  • Physician diagnosis of Atopic Dermatitis for >1 year with ≥ BSA involvement

12 visits during a 16 week period; Travel reimbursement-$50 per visits.

The Dermatology Group Location: Verona, NJ

For more information, call 1-(973)571-2121 ext. 5920 or email ctrials@thedermgroup.com

 

Or Contact The Verona Research Hotline 1-201-478-9119 Call or Text

The medication, procedures, and all study visits are provided without financial costs to you.  No insuranace coverage is required.  All enrolled participants will be compensated for their time and travel at the completion of the study.